beta-lactams has been researched along with Infection in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anjur, V; Bajaj, JS; Biggins, SW; Fallon, MB; Garcia-Tsao, G; Hu, C; Iyer, RK; Kamath, PS; Lai, JC; Maliakkal, B; O'Leary, J; Reddy, KR; Saboo, K; Subramanian, RM; Tandon, P; Thacker, LR; Thuluvath, P; Vargas, H; Wong, F | 1 |
| Görür, K; İsmi, O; Özcan, C; Vayisoğlu, Y; Yeşilova, M | 1 |
| Amiera Syuhada, N; Arslan Khan, M; Chean Ring, L; Ibrahim, D; Tan, WN; Yenn, TW | 1 |
| Abdul-Aziz, MH; Lipman, J; Roberts, JA | 1 |
| Beucher, G; Cazanave, C; Charlier, C | 1 |
| Chidiac, C; Ferry, T; Laurent, F; Ragois, P | 1 |
| Fujimura, A; Harada, K; Hasegawa, G; Hayasaka, T; Maeda, A; Saito, T; Tsuruoka, S; Ushijima, K | 1 |
| Clarke, MJ; Edwards, SJ; Welton, NJ; Wordsworth, S | 1 |
| Gonçalves-Pereira, J; Póvoa, P | 1 |
| Chokloikaew, S; Danpakdi, K; Thamlikitkul, V | 1 |
| Liu, HH | 1 |
| Yogev, R | 1 |
3 review(s) available for beta-lactams and Infection
| Article | Year |
|---|---|
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Infections; Meropenem; Piperacillin; Thienamycins | 2011 |
Antibiotics and infectious diseases.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Humans; Infections; Quinolones | 1990 |
The role of beta-lactamase inhibitors in pediatrics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Child; Child, Preschool; Clinical Trials as Topic; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Infections; Mice | 1988 |
1 trial(s) available for beta-lactams and Infection
| Article | Year |
|---|---|
The role of beta-lactamase inhibitors in pediatrics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Child; Child, Preschool; Clinical Trials as Topic; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Infections; Mice | 1988 |
9 other study(ies) available for beta-lactams and Infection
| Article | Year |
|---|---|
Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Ascites; beta-Lactams; Clinical Decision Rules; Cohort Studies; End Stage Liver Disease; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hydrothorax; Infections; Kidney Diseases; Lactulose; Liver Cirrhosis; Logistic Models; Machine Learning; Male; Middle Aged; Mortality; Paracentesis; Patient Readmission; Proton Pump Inhibitors; Reproducibility of Results; Rifaximin; ROC Curve; Severity of Illness Index; Support Vector Machine; Water-Electrolyte Imbalance | 2021 |
Difficult Cases of Odontogenic Deep Neck Infections: A Report of Three Patients.
Topics: Adult; Ampicillin; beta-Lactams; Clindamycin; Drainage; Ertapenem; Focal Infection, Dental; Gentamicins; Humans; Infections; Klebsiella Infections; Male; Middle Aged; Neck; Periodontal Abscess; Streptococcal Infections; Sulbactam | 2017 |
Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infections; Microbial Sensitivity Tests; Stigmasterol | 2017 |
Identifying "at-risk" patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Humans; Infections; Intensive Care Units | 2017 |
[Diagnosis and management of intra-uterine infection: CNGOF Preterm Premature Rupture of Membranes Guidelines].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; Fever; France; Humans; Infections; Pregnancy; Pregnancy Complications, Infectious; Streptococcal Infections; Streptococcus agalactiae; Uterine Diseases | 2018 |
Post-traumatic chronic bone and joint infection caused by Butyricimonas spp, and treated with high doses of ertapenem administered subcutaneously in a 30-year-old obese man.
Topics: Accidents, Traffic; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Arm Injuries; Bacteria; beta-Lactams; Bone Diseases; Ertapenem; Fractures, Open; Humans; Infections; Joint Diseases; Male | 2015 |
Dialyzability of Faropenem in Infected Patients on Chronic Hemodialysis.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Female; Humans; Infections; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2017 |
Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.
Topics: beta-Lactams; Carbapenems; Hospitalization; Humans; Infections; Inpatients; Randomized Controlled Trials as Topic | 2009 |
Incidence of diarrhea and Clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, beta-lactams, or nonantibiotic medications.
Topics: Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Clindamycin; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitalization; Humans; Incidence; Infections; Male; Middle Aged; Prospective Studies | 1996 |